Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vinblastine and Methotrexate in Children With Desmoid Tumor (Aggressive Fibromatosis) Which is Recurrent or Not Amenable to Surgical Resection or Irradiation - A Pediatric Oncology Group Phase II Study

NCT00003019 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00003019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vinblastine and Methotrexate in Children With Desmoid Tumor (Aggressive Fibromatosis) Which is Recurrent or Not Amenable to Surgical Resection or Irradiation - A Pediatric Oncology Group Phase II Study
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
August 31, 1997
Completion date
September 30, 2006
Enrollment
28 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

desmoid tumor